logo

For the Inventor, By the Inventor

South San Francisco, CA, United States of America

Corsair Pharma, Inc.

Calculating rank
USPTO Granted Patents = 28


Forward Citations = 389

Loading Chart...
Loading Chart...

6 inventors (with patents filed for the assignee):

goldMedal Xiaoming Zhang (28 out of 68 patents)

silverMedal Meenakshi S Venkatraman (28 out of 41 patents)

bronzeMedal Cyrus K Becker (28 out of 48 patents)

4.  Gwenaella Rescourio (5 out of 18 patents)

5.  Jürg Roland Pfister (4 out of 12 patents)

6.  Jürg R Pfister (2 out of 2 patents)

7.  Jürg Pfister (0 patent)

8.  Jörg Pfister (0 patent)


Core Competencies:
Treprostinil
Derivatives
Compositions
Pharmaceuticals
Therapeutic Uses
Drug Formulations
Compounds
Medical Applications
Cardiovascular Treatments
Innovative Therapies

28 patents:

1. 12643847 - Treprostinil derivatives and compositions and uses thereof (2026-06-02),
2. 12365663 - Treprostinil derivative compounds and methods of using same (2025-07-22),
3. 11958822 - Treprostinil derivative compounds and methods of using same (2024-04-16),
4. 11866402 - Treprostinil derivatives and compositions and uses thereof (2024-01-09),
5. 11802105 - Treprostinil derivatives and compositions and uses thereof (2023-10-31),
6. 11505535 - Treprostinil derivative compounds and methods of using same (2022-11-22),
7. 11407707 - Treprostinil derivatives and compositions and uses thereof (2022-08-09),
8. 11339139 - Treprostinil derivative compounds and methods of using same (2022-05-24),
9. 11046666 - Treprostinil derivative compounds and methods of using same (2021-06-29),
10. 11034645 - Treprostinil derivatives and compositions and uses thereof (2021-06-15),
11. 10988435 - Treprostinil derivatives and compositions and uses thereof (2021-04-27),
12. 10759733 - Treprostinil derivatives and compositions and uses thereof (2020-09-01),
13. 10752605 - Treprostinil derivative compounds and methods of using same (2020-08-25),
14. 10703706 - Treprostinil derivatives and compositions and uses thereof (2020-07-07),
15. 10464878 - Treprostinil derivatives and compositions and uses thereof (2019-11-05),
Company Overview
Corsair Pharma, Inc. is a biotechnology company based in South San Francisco, California, focused on developing innovative therapeutics for various diseases. The organization specializes in drug discovery and development, leveraging advanced technologies to create novel treatments that address unmet medical needs. With a commitment to scientific excellence, Corsair Pharma aims to transform the landscape of healthcare through its research in pharmacology and molecular biology, contributing to the advancement of precision medicine.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

Corsair Pharma, Inc. USPTO Patent Assignee Logo
28 Patents

#47 in South San Francisco, CA

#2,850 in California

#12,022 in US

#23,317 in the World

South San Francisco, CA (US)
South San Francisco, CA, United States of America

Corsair Pharma, Inc.

Forward Citations = 389

6 inventors:

goldMedal Xiaoming Zhang (28 out of 68 patents)

silverMedal Meenakshi S Venkatraman (28 out of 41 patents)

bronzeMedal Cyrus K Becker (28 out of 48 patents)

4.  Gwenaella Rescourio (5 out of 18 patents)

5.  Jürg Roland Pfister (4 out of 12 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Corsair Pharma, Inc.. Retrieved from https://idiyas.com/company/corsair-pharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…